Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/3015% above fair value
$4.13−0.28 (-6.35%)
Close on Nov 13, 2026Market cap $100.05MP/E –Yield –
Exagen enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Exagen's enterprise value was $120.06M on Nov 11, 2026, against $164.92M a year earlier. Over the last 5 years it ranged from -$8.82M to $249.47M, with a median of $50.79M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $120.06M | -3.1% |
| 2025 | Dec 31, 2025 | $123.95M | +77.5% |
| 2024 | Dec 31, 2024 | $69.85M | +185.1% |
| 2023 | Dec 29, 2023 | $24.50M | – |
| 2022 | Dec 30, 2022 | -$1.76M | -101.6% |
| 2021 | Dec 31, 2021 | $108.51M | -17.7% |
| 2020 | Dec 31, 2020 | $131.93M | -50.5% |
| 2019 | Dec 31, 2019 | $266.76M | – |
See a number that looks wrong?